Daxor Corporation (DXR)
NASDAQ: DXR · IEX Real-Time Price · USD
9.88
+0.22 (2.28%)
May 2, 2024, 4:00 PM EDT - Market closed

Daxor Revenue

In the year 2023, Daxor had annual revenue of $34.59M with 448.16% growth. Revenue in the quarter ending December 31, 2023 was $36.35M, a -11,314.54% decrease year-over-year.

Revenue (ttm)
$34.67M
Revenue Growth
-18,720.02%
P/S Ratio
1.35
Revenue / Employee
$937,080
Employees
37
Market Cap
46.78M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202334.59M28.28M448.16%
Dec 31, 20226.31M489.11K8.40%
Dec 31, 20215.82M6.82M-684.28%
Dec 31, 2020-996.30K-881.31K766.41%
Dec 31, 2019-114.99K803.46K-87.48%
Dec 31, 2018-918.45K93.14K-9.21%
Dec 31, 2017-1.01M-2.85M-155.12%
Dec 31, 20161.84M9.28M-124.66%
Dec 31, 2015-7.44M-3.39M83.63%
Dec 31, 2014-4.05M7.50M-64.93%
Dec 31, 2013-11.56M-9.46M449.78%
Dec 31, 2012-2.10M-3.38M-264.57%
Dec 31, 20111.28M-301.84K-19.11%
Dec 31, 20101.58M-109.57K-6.49%
Dec 31, 20091.69M-72.23K-4.10%
Dec 31, 20081.76M-108.72K-5.81%
Dec 31, 20071.87M383.33K25.79%
Dec 31, 20061.49M142.91K10.64%
Dec 31, 20051.34M125.13K10.27%
Dec 31, 20041.22M-1.95M-61.51%
Dec 31, 20033.17M463.50K17.15%
Dec 31, 20022.70M1.94M256.28%
Dec 31, 2001758.37K12.58K1.69%
Dec 31, 2000745.79K170.41K29.62%
Dec 31, 1999575.38K275.38K91.79%
Dec 31, 1998300.00K-200.00K-40.00%
Dec 31, 1997500.00K-2.30M-82.14%
Dec 31, 19962.80M-1.90M-40.43%
Dec 31, 19954.70M100.00K2.17%
Dec 31, 19944.60M-200.00K-4.17%
Dec 31, 19934.80M-1.30M-21.31%
Dec 31, 19926.10M2.20M56.41%
Dec 31, 19913.90M-700.00K-15.22%
Dec 31, 19904.60M2.40M109.09%
Dec 31, 19892.20M-2.20M-50.00%
Dec 31, 19884.40M2.50M131.58%
Dec 31, 19871.90M100.00K5.56%
Dec 31, 19861.80M--
Dec 31, 19851.80M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cutera 230.18M
Nortech Systems 139.33M
IRIDEX 51.87M
Cytosorbents 36.35M
Aadi Bioscience 24.35M
InspireMD 6.21M
Matinas BioPharma Holdings 1.10M
Revenue Rankings